应用菲立磁MR成像检测干细胞移植排斥:MR成像表现与活体显微镜所见的相关性
研究在大鼠膝关节骨软骨缺损和小鼠颅骨缺损模型中,经静脉注射菲立磁后行系列MR成像与活体显微镜检查,发现免疫错配干细胞植入物的菲立磁强化强于免疫匹配植入物,4周时错配植入物T2值显著更低,与巨噬细胞募集增加相对应。结论认为菲立磁对巨噬细胞的内源性标记使MR成像能够无创检测对干细胞移植的先天免疫反应。
要点
- 免疫错配干细胞植入物的菲立磁强化强于免疫匹配植入物。
- 4周时错配植入物T2值显著低于匹配植入物。
- T2值降低与活体显微镜下增强型GFP及罗丹明-菲立磁阳性巨噬细胞募集增加相对应。
核心结论
- 菲立磁对巨噬细胞的内源性标记使MR成像能够无创检测对干细胞移植的先天免疫反应。
研究设计与样本
- 九只免疫健全Sprague-Dawley大鼠经静脉注射菲立磁,18只Jax C57BL/6-Tg(Csf1r-EGFP-NGFR/FKBP1A/TNFRSF6)2Bck/J小鼠经静脉注射罗丹明偶联菲立磁,48小时后将免疫匹配或错配干细胞植入大鼠膝关节骨软骨缺损和小鼠颅骨缺损,所有动物术后行系列MR成像与活体显微镜检查至4周。
关键影像表现/征象
- 免疫错配干细胞植入物显示比匹配干细胞植入物更强的菲立磁强化。
- 4周时雌性大鼠骨软骨缺损中错配植入物T2值显著低于匹配植入物:人干细胞平均10.72毫秒、雄性大鼠干细胞平均11.55毫秒 vs 性别匹配大鼠干细胞平均15.45毫秒(P=.02和P=.04)。
- 4周时受体小鼠颅骨缺损中错配植入物T2值平均21.7毫秒 vs 匹配植入物平均27.1毫秒(P=.0444)。
- 活体显微镜和组织病理学检查显示增强型GFP及罗丹明-菲立磁阳性巨噬细胞向干细胞植入物募集增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To determine whether endogenous labeling of macrophages with clinically applicable nanoparticles enables noninvasive detection of innate immune responses to stem cell transplants with magnetic resonance (MR) imaging. Materials and Methods Work with human stem cells was approved by the institutional review board and the stem cell research oversight committee, and animal experiments were approved by the administrative panel on laboratory animal care. Nine immunocompetent Sprague-Dawley rats received intravenous injection of ferumoxytol, and 18 Jax C57BL/6-Tg (Csf1r-EGFP-NGFR/FKBP1A/TNFRSF6) 2Bck/J mice received rhodamine-conjugated ferumoxytol. Then, 48 hours later, immune-matched or mismatched stem cells were implanted into osteochondral defects of the knee joints of experimental rats and calvarial defects of Jax mice. All animals underwent serial MR imaging and intravital microscopy (IVM) up to 4 weeks after surgery. Macrophages of Jax C57BL/6-Tg (Csf1r-EGFP-NGFR/FKBP1A/TNFRSF6) 2Bck/J mice express enhanced green fluorescent protein (GFP), which enables in vivo correlation of ferumoxytol enhancement at MR imaging with macrophage quantities at IVM. All quantitative data were compared between experimental groups by using a mixed linear model and t tests. Results Immune-mismatched stem cell implants demonstrated stronger ferumoxytol enhancement than did matched stem cell implants. At 4 weeks, T2 values of mismatched implants were significantly lower than those of matched implants in osteochondral defects of female rats (mean, 10.72 msec for human stem cells and 11.55 msec for male rat stem cells vs 15.45 msec for sex-matched rat stem cells; P = .02 and P = .04, respectively) and calvarial defects of recipient mice (mean, 21.7 msec vs 27.1 msec, respectively; P = .0444). This corresponded to increased recruitment of enhanced GFP- and rhodamine-ferumoxytol-positive macrophages into stem cell transplants, as visualized with IVM and histopathologic examination. Conclusion Endogenous labeling of macrophages with ferumoxytol enables noninvasive detection of innate immune responses to stem cell transplants with MR imaging. © RSNA, 2017 Online supplemental material is available for this article.
引用
- Daldrup-Link HE, Chan C, Lenkov O, et al. Detection of Stem Cell Transplant Rejection with Ferumoxytol MR Imaging: Correlation of MR Imaging Findings with Those at Intravital Microscopy. Radiology. 2017. PMID: 28128708. doi:10.1148/radiol.2017161139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。